Study of the Safety and Efficacy of APR-246 in Combination With Azacitidine

Clinical trial NCT03588078 · UNKNOWN

Trial details

NCT number: NCT03588078
Sponsor: Groupe Francophone des Myelodysplasies
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Myelodysplastic Syndrome With Gene Mutation Acute Myeloid Leukemia With Gene Mutations Myeloproliferative Neoplasm Chronic Myelomonocytic Leukemia

Start date: 2018-09-15
Primary completion: 2020-05-01
Enrollment: 53

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.